Skip to Main Content
  • OMMBID Advisory banner
  • Ommbid banner
  • Ommbid latest banner
  • OMMBID Blog Promo

Abstract

Abstract 

  1. Familial hyperlysinemia is an autosomal recessive disease caused by a defect in the bifunctional protein α-aminoadipic semialdehyde synthase. The two associated enzyme activities, lysine-ketoglutarate reductase and saccharopine dehydrogenase, normally initiate the degradation of lysine by removal of the ε amino group. In familial hyperlysinemia, both activities are reduced to 10 percent of normal or less, causing hyperlysinemia and lysinuria, frequently accompanied by a relatively mild saccharopinuria. The condition appears to be benign. A variant, saccharopinuria, has been described in which 30 percent of lysine-ketoglutarate activity was retained and the saccharopine dehydrogenase activity was undetectable. Saccharopinuria was prominent, exceeding the associated lysinuria. Experience with the variant is too limited to know if this metabolic abnormality causes disease.

  2. Removal of the α amino group of lysine constitutes a minor pathway for lysine degradation in most tissues, with pipecolic acid as a product. Hyperpipecolatemia is regularly observed in familial hyperlysinemia as an overflow phenomenon. It is also a common concomitant of Zellweger syndrome, as the result of a defect in peroxisome formation and the consequent deficiency of L-pipecolic acid oxidase activity. A convincing example of a patient with hyperpipecolatemia as a primary defect has not been reported. The hyperpipecolatemia in Zellweger syndrome becomes manifest after the major symptoms are already evident, suggesting that it is not a significant contributing factor.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.